These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12387706

  • 1. Fabry disease: recent advances in enzyme replacement therapy.
    Germain DP.
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1467-76. PubMed ID: 12387706
    [Abstract] [Full Text] [Related]

  • 2. [Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects].
    Germain DP.
    J Soc Biol; 2002 Oct; 196(2):161-73. PubMed ID: 12360745
    [Abstract] [Full Text] [Related]

  • 3. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
    Germain DP.
    J Soc Biol; 2002 Oct; 196(2):183-90. PubMed ID: 12360747
    [Abstract] [Full Text] [Related]

  • 4. Advances in the management of Anderson-Fabry disease: enzyme replacement therapy.
    Pastores GM, Thadhani R.
    Expert Opin Biol Ther; 2002 Mar; 2(3):325-33. PubMed ID: 11890871
    [Abstract] [Full Text] [Related]

  • 5. Fabry disease.
    Germain DP.
    Orphanet J Rare Dis; 2010 Nov 22; 5():30. PubMed ID: 21092187
    [Abstract] [Full Text] [Related]

  • 6. Enzyme replacement therapy in Fabry disease: clinical implications.
    Breunig F, Knoll A, Wanner C.
    Curr Opin Nephrol Hypertens; 2003 Sep 22; 12(5):491-5. PubMed ID: 12920395
    [Abstract] [Full Text] [Related]

  • 7. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
    Mignani R, Cagnoli L.
    J Nephrol; 2004 Sep 22; 17(3):354-63. PubMed ID: 15365954
    [Abstract] [Full Text] [Related]

  • 8. Fabry disease: molecular genetics of the inherited nephropathy.
    Desnick RJ, Astrin KH, Bishop DF.
    Adv Nephrol Necker Hosp; 1989 Sep 22; 18():113-27. PubMed ID: 2564247
    [Abstract] [Full Text] [Related]

  • 9. [Fabry disease. Clinical and genetic aspects. Therapeutic perspectives].
    Germain DP.
    Rev Med Interne; 2000 Dec 22; 21(12):1086-103. PubMed ID: 11191676
    [Abstract] [Full Text] [Related]

  • 10. Fabry disease in the era of enzyme replacement therapy: a renal perspective.
    Cho ME, Kopp JB.
    Pediatr Nephrol; 2004 Jun 22; 19(6):583-93. PubMed ID: 15064943
    [Abstract] [Full Text] [Related]

  • 11. Enzyme replacement therapy in Fabry disease: influence on cardiac manifestations.
    Caballero L, Climent V, Hernández-Romero D, Quintanilla MA, de la Morena G, Marín F.
    Curr Med Chem; 2010 Jun 22; 17(16):1679-89. PubMed ID: 20345350
    [Abstract] [Full Text] [Related]

  • 12. [Management of Fabry disease].
    Constantin T, Székely A, Ponyi A, Gulácsy V, Ambrus C, Kádár K, Vastagh I, Dajnoki A, Tóth B, Bokrétás G, Müller V, Katona M, Medvecz M, Fiedler O, Széchey R, Varga E, Rudas G, Kertész A, Molnár S, Kárpáti S, Nagy V, Magyar P, Mahdi M, Rákóczi E, Németh K, Bereczki D, Garami M, Erdos M, Maródi L, Fekete G.
    Orv Hetil; 2010 Aug 01; 151(31):1243-51. PubMed ID: 20656661
    [Abstract] [Full Text] [Related]

  • 13. Enzyme replacement therapy for Fabry disease, an inherited nephropathy.
    Desnick RJ, Banikazemi M, Wasserstein M.
    Clin Nephrol; 2002 Jan 01; 57(1):1-8. PubMed ID: 11837797
    [Abstract] [Full Text] [Related]

  • 14. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A, Osterziel KJ, Beck M, Dietz R, Kampmann C.
    Herz; 2002 Nov 01; 27(7):699-702. PubMed ID: 12439642
    [Abstract] [Full Text] [Related]

  • 15. Anderson-Fabry disease in Austria.
    Lorenz M, Hauser AC, Püspök-Schwarz M, Kotanko P, Arias I, Zodl H, Kramar R, Paschke E, Voigtländer T, Sunder-Plassmann G.
    Wien Klin Wochenschr; 2003 Apr 30; 115(7-8):235-40. PubMed ID: 12778775
    [Abstract] [Full Text] [Related]

  • 16. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
    Breunig F, Wanner C.
    J Nephrol; 2008 Apr 30; 21(1):32-7. PubMed ID: 18264934
    [Abstract] [Full Text] [Related]

  • 17. The heart in Fabry's disease.
    Sheppard MN.
    Cardiovasc Pathol; 2011 Apr 30; 20(1):8-14. PubMed ID: 19919901
    [Abstract] [Full Text] [Related]

  • 18. [Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature].
    Riccio E, Capuano I, Visciano B, Marchetiello C, Petrillo F, Pisani A.
    G Ital Nefrol; 2013 Apr 30; 30(5):. PubMed ID: 24402625
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.
    Banikazemi M, Ullman T, Desnick RJ.
    Mol Genet Metab; 2005 Aug 30; 85(4):255-9. PubMed ID: 15939645
    [Abstract] [Full Text] [Related]

  • 20. Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.
    Pisani A, Spinelli L, Sabbatini M, Andreucci MV, Procaccini D, Abbaterusso C, Pasquali S, Savoldi S, Comotti C, Cianciaruso B.
    Am J Kidney Dis; 2005 Jul 30; 46(1):120-7. PubMed ID: 15983965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.